At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,392 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multinational, Observational Follow-Up Study of the Incidence of Cancer and Mortality in Patients From the SEAS Trial
In Brief
An observational study for Cancer. Completed, enrolled 1,392 participants.
Detailed Summary
The purpose of this extension is to observe the incidence rates of cancer, total mortality, and mortality due to cancer over a 21 month follow-up period in patients from the SEAS trial (2004\_050, MK0653A-043; NCT00092677).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCancer
Countries--
CollaboratorsInstitute of Applied Economics Aps, Denmark
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedMar 2010
Enrollment StartMar 2010
Primary CompletionFeb 2013
Study CompletionApr 2013
TodayJul 2026
First PostedMar 1, 2010
Enrollment StartMar 1, 2010
Primary CompletionFeb 1, 2013
Study CompletionApr 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 16.3 years ago